Downregulation of the endothelin system of lung myofibroblasts in congestive heart failure

Journal of Cardiovascular Pharmacology

Volumn 54, Issue 2, 2009, Pages 147-153

  Préfontaine, Annick ^a   Calderone, Angelino ^b   Dupuis, Jocelyn ^b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cardiomyopathy; Cell culture; Endothelin; Myofibroblasts; Receptors; Remodelling; Vasoactive peptides

Indexed keywords

BROXURIDINE; ENDOTHELIN 1; LEUCINE; THYMIDINE; VIMENTIN;

ARTICLE; CELL PROLIFERATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOWN REGULATION; HEART INFARCTION; LUNG; LUNG ALVEOLUS WALL; MALE; MITOGENESIS; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ENDOTHELIN-1; FIBROBLASTS; HEART FAILURE; LUNG; MALE; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B;

EID: 74249095119     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181ad7d57     Document Type: Article

References (28)

1. Gehlbach BK, Geppert E. The pulmonary manifestations of left heart failure. Chest. 2004;125:669-682.
2. Huang W, Kingsbury MP, Turner MA, et al. Capillary filtration is reduced in lungs adapted to chronic heart failure: morphological and haemodynamic correlates. Cardiovasc Res. 2001;49:207-217.
3. Jasmin JF, Calderone A, Leung TK, et al. Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan. Cardiovasc Res. 2003;58:621-631.
4. Kingsbury MP, Huang W, Donnelly JL, et al. Structural remodelling of lungs in chronic heart failure. Basic Res Cardiol. 2003;98: 295-303.
5. Guazzi M, Pontone G, Brambilla R, et al. Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J. 2002;23:467-476.
6. Puri S, Baker BL, Dutka DP, et al. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation. 1995; 91:2769-2774.
7. Pousset F, Isnard R, Lechat P, et al. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J. 1997;18: 254-258.
8. Dupuis J. Increased endothelin levels in congestive heart failure: Does it come from the lungs? Does it matter? Cardiovasc Res. 2004; 63:5-7.
9. von Lueder TG, Kjekshus H, Edvardsen T, et al. Mechanisms of elevated plasma endothelin-1 in CHF: Congestion increases pulmonary synthesis and secretion of endothelin-1. Cardiovasc Res. 2004;63:41-50.
10. Lepailleur-Enouf D, Egidy G, Philippe M, et al. Pulmonary endothelinergic system in experimental congestive heart failure. Cardiovasc Res. 2001;49:330-339.
11. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993; 328:1732-1739. (Pubitemid 23170122)
12. Gallelli L, Pelaia G, D'Agostino B, et al. Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases. J Cell Biochem. 2005;96:858-868.
13. Shi-Wen X, Denton CP, Dashwood MR, et al. Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1. J Invest Dermatol. 2001;116:417-425.
14. Peacock AJ, Dawes KE, Shoc A, et al. Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol. 1991;7:492-499.
15. Nguyen QT, Colombo F, Rouleau JL, et al. LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction. Br J Pharmacol. 2000;130:1525-1530.
16. Kapanci YS, Burgan G, Pietra G, et al. Modulation of actin isoform expression in alveolar myofibroblasts (contractile interstitial cells) during pulmonary hypertension. Am J Pathol. 1990;36:881-889.
17. Agostoni P, Bussotti M, Cattadori G, et al. Gas diffusion and alveolarcapillary unit in chronic heart failure. Eur Heart J. 2006;27: 2538-2543.
18. Guazzi M, Reina G, Tumminello G, et al. Alveolar-capillary membrane conductance is the best pulmonary function correlate of exercise ventilation efficiency in heart failure patients. Eur J Heart Fail. 2005; 7:1017-1022.
19. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334: 1349-1355.
20. Galatius-Jensen S, Wroblewski H, Emmeluth C, et al. Plasma endothelin in congestive heart failure: a predictor of cardiac death? J Card Fail. 1996; 2:71-76. (Pubitemid 126666356)
21. Cody RJ, Haas GJ, Binkley PF, et al. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 1992;85:504-509.
22. Xu S, Denton CP, Holmes A, et al. Endothelins: effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblasts. J Cardiovasc Pharmacol. 1998;31(Suppl 1):S360-S363.
23. Solini A, Santini E, Madec S, et al. Effects of endothelin-1 on fibroblasts from type 2 diabetic patients: Possible role in wound healing and tissue repair. Growth Fact. 2007;25:392-399.
24. Linden J, Patel A, Spanier AM, et al. Rapid agonist-induced decrease of 125I-pindolol binding to beta-adrenergic receptors. Relationship to desensitization of cyclic AMP accumulation in intact heart cells. J Biol Chem. 1984;259:15115-15122.
25. Bobik A, Campbell JH, CarsonV, et al. Mechanism of isoprenalineinduced refractoriness of the beta-adrenoceptor-adenylate cyclase system in chick embryo cardiac cells. J Cardiovasc Pharmacol. 1981;3:541-553.
26. Reithmann C,Werdan K. Homologous vs. heterologous desensitization of the adenylate cyclase system in heart cells. Eur J Pharmacol. 1988;54:99-104.
27. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154-e235.
28. Moe GW, Rouleau JL, Nguyen QT, et al. Role of endothelins in congestive heart failure. Can J Physiol Pharmacol. 2003;81: 588-597.